logo-loader
viewAmphion Innovations PLC

Amphion Innovations - Stmnt re Share Price Movement

RNS Number : 3698P
Amphion Innovations PLC
07 February 2019
 

 

AMPHION INNOVATIONS PLC

 ("Amphion" or "the Company")

 

Statement regarding Price Movement

 

London and New York, Amphion Innovations plc (AIM: AMP), the developer of medical, life science, and technology businesses, notes the recent movement in its share price and, notwithstanding the recent share price increase of its Partner Companies Motif Bio plc ("Motif"), in which the Company has a holding of approximately 8.5 per cent. and Polarean Imaging Plc in which the Company has a holding of approximately 18.2 per cent., confirms that it is not aware of any specific reason for this movement.

 

The Company remains cash constrained and as previously announced continues to consider both its short term and medium-term funding options and work with the Company's debt providers, including the Convertible Promissory Note ("CPN") holders with whom the Company has been able to reach accommodations in the past. The Company is proposing to extend the term of the debt to 31 December 2019 following expiration of the CPN on 31 December 2018. A further announcement will be made in this regard in due course.

 

 

 

For further information please contact:

 

Amphion Innovations

Tel: +1 (212) 210 6224

Charlie Morgan




Panmure Gordon Limited (Nominated Adviser and Corporate Broker)

Tel: +44 (0)20 7886 2500

Emma Earl/ Freddy Crossley (Corporate Finance)


Charles Leigh-Pemberton (Corporate Broking)




SP Angel Corporate Finance LLP (Joint Corporate Broker)

Tel: +44 20 3470 0470

David Hignell (Corporate Finance)


Vadim Alexandre (Corporate Broking)




Walbrook PR

Tel: +44 (0)20 7933 8780 or [email protected]

Anna Dunphy / Paul McManus




 

 

 

About Amphion Innovations plc

Amphion Innovations is a developer of medical, life science and technology businesses. We use our extensive experience in company building to invest and build shareholder value in high growth companies in the US and UK. Amphion has significant shareholding in 7 Partner Companies developing proven technologies targeting substantial commercial marketplaces. The Amphion model has been refined to optimise the commercialisation of patents and other intellectual property within the Partner Companies. The Partner Companies collectively own or control over 200 separately identified pieces of intellectual property, a number which grows rapidly each year.

 

On the web: www.amphionplc.com 

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
SPMUGURWPUPBUBM

Quick facts: Amphion Innovations PLC

Price: -

Market: AIM
Market Cap: -
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Amphion Innovations president on significant partner developments and strategy

Bob Bertoldi, president of Amphion Innovations PLC (LON:AMP) caught up with Proactive London’s Andrew Scott to discuss some of the big 2018 developments at the partner companies including Polarean Imaging (LON:POLX) and Motif Bio PLC (LON:MTFB) Polarean’s recently raised US$4mln through a...

on 14/12/18